BioLargo, Inc.’s CEO Discusses Business Milestones and FDA Progress with Uptick Newswire’s Stock Day Podcast
05. November 2018 08:00 ET
|
BioLargo, Inc.
PHOENIX, Nov. 05, 2018 (GLOBE NEWSWIRE) -- Dennis Calvert, CEO of BioLargo, Inc. (OTCQB:BLGO), recently spoke with Stock Day Podcast’s Everett Jolly to update listeners on the company’s recent...
BioLargo acquires breakthrough stem cell therapy technology to expand medical product portfolio
02. Oktober 2018 08:00 ET
|
BioLargo, Inc.
WESTMINSTER, Calif., Oct. 02, 2018 (GLOBE NEWSWIRE) -- BioLargo, Inc. (OTCQB:BLGO), developer of sustainable science and technologies and a full-service environmental engineering company, announced...
BioLargo CEO Dennis Calvert Elaborates on the Importance of its new Engineering Division and Financing to Accelerate Commercialization
20. September 2017 10:00 ET
|
BioLargo, Inc.
Phoenix, AZ, Sept. 20, 2017 (GLOBE NEWSWIRE) -- Dennis Calvert, CEO of BioLargo, Inc. (OTCQB: BLGO) was interviewed on the Uptick Network Stock Day Podcast with host Everett Jolly. In the interview...
BioLargo Achieves Important Milestones - Sales Increase by 176%
15. August 2017 10:45 ET
|
BioLargo, Inc.
Westminster, CA , Aug. 15, 2017 (GLOBE NEWSWIRE) -- BioLargo Achieves Important Milestones - Sales Increase by 176% Westminster, CA – August 15, 2017 – BioLargo, Inc., (OTCQB: BLGO;...